FDA Alerts
FDA Approves Generic Boniva
The U.S. Food and Drug Administration approved the first generic versions of Boniva ( ibandronate ) tablets, a once-monthly product to treat or prevent osteoporosis in women after menopause.
FDA Drug Safety Communication: Bisphosphonates and Esophageal Cancer
The U.S. Food and Drug Administration (FDA) is continuing to review data from published studies to evaluate whether use of oral bisphosphonate drugs is associated with an increased risk of cancer of the esophagus (esophageal cancer).